Procurement Summary
Country : Brazil
Summary : Purchase of Compounded Medications in Installments (Dapsone 100Mg Cap and Others), to Serve the Chc/Ufpr.
Deadline : 22 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 98577003
Document Ref. No. : 90012/2024
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition in installments of compounded medicines (dapsone 100mg cap and others), to meet CHC/UFPR.
UASG Code: 155902
Notice from: 11/03/2024 from 08:00 to 17:00 Hs
Proposal Delivery: from 03/11/2024 at 08:00Hs
DAPSONA (DDS), DOSAGE 100 MG
Wed19981d172c851bd4e8a1788d5726c2d3Quantity: 600
AMINOPHYLLINE, DOSAGE 24 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1200
FERRIC CHLORIDE, CONCENTRATION 80%, GEL PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION
Quantity: 60
CHOLESTYRAMINE, DO SAGEM 4G, POWDER PRESENTATION
Quantity: 600
COLO19981d172c851bd4e8a1788d5726c2d3ELASTIC DIO, COMPOSITION COMP.: CAMPHOR 2%, CASTOR OIL 3% AND COLLODIUM QSP
Quantity: 48
ISOPRENALINE, CONCENTRATION 0.2 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION
Quantity: 120
MET ILTHIONIUM CHLORIDE, CONCENTRATION 1%, INJECTION INJECTION19981d172c851bd4e8a1788d5726c2d3TABLE
Quantity: 1600
SILVER NITRATE, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION
Quantity: 240
CODEINE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION- DROPS, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED
Quantity: 100
COAL ACTIVATED, PHARMACEUTICAL POWDER FORM
Q19981d172c851bd4e8a1788d5726c2d3quantity: 60
ACETIC ACID, CONCENTRATION 5%, PHARMACEUTICAL FORM TOPICAL SOLUTION, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION
Quantity: 150
TRICHLOROACETIC ACID (TCA), DOSAGE 80%, PRESENTATION AQUEOUS SOLUTION
Quantity: 50
DEHYDROxIDE POTASSIUM, CONCENTRATION A 10%, PHARMAC FORM19981d172c851bd4e8a1788d5726c2d3CEUTICA AQUEOUS SOLUTION, ADDITIONAL SPECIALLY HANDLED FORMULATION
Quantity: 50
CHLORAL HYDRATE, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED
Quantity: 70
DYE, LUGOL FORTE TYPE, ADDITIONAL CHARACTERISTICS IONALS SOLUTION 2%
Quantity19981d172c851bd4e8a1788d5726c2d3age: 12
SORBITOL, PHYSICAL APPEARANCE SYRUPUS LIQUID, CLEAR, I...
Documents
Tender Notice